Affy, Caliper, Luminex Added Back to Nasdaq Biotech Index | GenomeWeb

NEW YORK, July 17 (GenomeWeb News) - The Nasdaq exchange said on Friday that it has reinstated several genomics companies that it dropped from the Nasdaq Biotechnology Index in May.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.